Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0676 CHF | +14.58% | -2.03% | +64.88% |
May. 01 | SIX Swiss Exchange Approves Delay in Spexis' FY23 Annual Report Publication | MT |
Apr. 17 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
- Stock Market
- Equities
- POLN Stock
- News Spexis AG
- MarketScreener Strategies